Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NAOV NanoVibronix Inc
- Stocks
- Healthcare
- NASDAQ: NAOV
Price (delayed)
$1.04
Market cap
$2.69M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$15.18
Enterprise value
$6M
NanoVibronix, Inc. is a medical device company headquartered in Elmsford, New York, with research and development in Nesher, Israel, focused on developing medical devices utilizing its patented low intensity surface
Highlights
NanoVibronix's EPS has increased by 18% YoY but it has decreased by 11% from the previous quarter
NanoVibronix's revenue has decreased by 7% YoY but it has increased by 4.1% from the previous quarter
NanoVibronix's quick ratio has plunged by 90% YoY and by 61% from the previous quarter
The net income has dropped by 75% year-on-year and by 51% since the previous quarter
Key stats
What are the main financial stats of NAOV
Market
Valuations
Earnings
Shares outstanding
2.58M
Market cap
$2.69M
Enterprise value
$6M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.02
Price to sales (P/S)
0.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.26
Revenue
$2.66M
Gross profit
$1.21M
Operating income
-$4.87M
Net income
-$5.61M
EBIT
-$5.43M
EBITDA
-$5.41M
Free cash flow
-$3.29M
Per share
Balance sheet
Liquidity
EPS
-$15.18
EPS diluted
-$15.18
Free cash flow per share
-$5.25
Book value per share
$46.98
Revenue per share
$4.25
TBVPS
$6.89
Total assets
$44.11M
Total liabilities
$8.43M
Debt
$3.92M
Equity
$35.68M
Working capital
-$4.34M
Debt to equity
0.11
Current ratio
0.47
Quick ratio
0.12
Net debt/EBITDA
-0.61
Margins
Efficiency
Dividend
EBITDA margin
-203.3%
Gross margin
45.6%
Net margin
-210.8%
Operating margin
-182.8%
Return on assets
-38.6%
Return on equity
-54.7%
Return on invested capital
-1,215%
Return on capital employed
-15.1%
Return on sales
-204%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NAOV stock price
How has the NanoVibronix stock price performed over time
Intraday
0%
1 week
21.55%
1 month
-75.81%
1 year
-88.03%
YTD
-83.98%
QTD
-69.5%
Financial performance
How have NanoVibronix's revenue and profit performed over time
Revenue
$2.66M
Gross profit
$1.21M
Operating income
-$4.87M
Net income
-$5.61M
Gross margin
45.6%
Net margin
-210.8%
NAOV's net margin has dropped by 88% year-on-year and by 46% since the previous quarter
NAOV's operating margin has shrunk by 77% YoY and by 31% QoQ
The net income has dropped by 75% year-on-year and by 51% since the previous quarter
NAOV's operating income has plunged by 65% YoY and by 36% from the previous quarter
Price vs fundamentals
How does NAOV's price correlate with its fundamentals
Growth
What is NanoVibronix's growth rate over time
Valuation
What is NanoVibronix stock price valuation
P/E
N/A
P/B
0.02
P/S
0.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.26
NanoVibronix's EPS has increased by 18% YoY but it has decreased by 11% from the previous quarter
NAOV's P/B is 99% below its 5-year quarterly average of 2.9 and 98% below its last 4 quarters average of 1.3
The P/S is 98% below the 5-year quarterly average of 13.0 and 60% below the last 4 quarters average of 0.6
NanoVibronix's revenue has decreased by 7% YoY but it has increased by 4.1% from the previous quarter
Efficiency
How efficient is NanoVibronix business performance
NanoVibronix's ROS has plunged by 97% YoY and by 46% from the previous quarter
The ROE has soared by 67% since the previous quarter and by 43% year-on-year
The ROA has grown by 47% from the previous quarter and by 27% YoY
Dividends
What is NAOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NAOV.
Financial health
How did NanoVibronix financials performed over time
NAOV's total liabilities has soared by 181% QoQ
NanoVibronix's quick ratio has plunged by 90% YoY and by 61% from the previous quarter
NAOV's debt is 89% smaller than its equity
NAOV's debt to equity is down by 42% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.